Summer may be halfway through, but momentum across the EIC Scaling Club community is only building.
In this edition, we spotlight new stories from the EIC Scaling Club network, including interviews with company founders, CEOs and industry experts.
Get ready to:
Meet EIC Scaling Club companies Kern Tec, Sentante, Osivax and HSL Technologies;
Celebrate major funding rounds from FOSSA, H2SITE and Sherpa.ai;
Discover key insights from our latest 'EIC Scaling Club Case' report;
Watch new interviews with Club company founders, CEOs and industry experts.
Happy reading,
The EIC Scaling Club team
EIC Scaling Club Members in the Spotlight
Austrian company Kern Tec brings a circular touch to food tech, as it turns overlooked agricultural side streams into sustainable raw materials. Read the article to learn how they transform apricot, cherry and plum kernels into high-value ingredients for the food and cosmetics industries.
Lithuania-based company Sentante is changing how we perform modern endovascular procedures. Part of the Health Tech market group, their teleoperated robotic system enables physicians to carry out complex vascular interventions from a completely remote workstation.
Lyon-based Osivax is a clinical-stage biopharmaceutical company developing vaccines designed to provide broad-spectrum protection against highly mutating infectious viruses. Its lead programme, OVX836, is a broad-spectrum influenza A vaccine developed using the company’s oligoDOM™ self-assembling nanoparticle platform.
French deep tech company HSL Technologies is rethinking a niche but important part of industrial supply chains: precipitated silica. Its patented HydroSil technology uses a liquid carrier route to produce and transport precipitated silica more efficiently, while also generating hydrogen as a valuable by-product.
The Corporate Venturing Ecosystem Report explores how policymakers can better support collaboration between deep tech scale-ups, large corporates, medium-sized enterprises and midcaps. It also looks at the barriers that still slow down these partnerships, including procurement complexity, misaligned incentives and limited innovation capacity.
The Scale-Up Financing Report explores Europe's growth capital gap and what policymakers, investors and institutions can do to help close it.
The insights reveal the barriers that continue to prevent high-growth companies from accessing the capital they need to scale globally, including fragmented capital markets, limited late-stage funding and investment models that do not reflect deep-tech development timelines.
The Innovation Procurement Report examines how policymakers can make public demand more accessible to deep-tech scale-ups across Europe.
The findings highlight the obstacles that continue to hold innovative companies back, from complex procedures and lengthy timelines to fragmented rules and limited access to public-sector buyers.
The latest EIC Scaling Club report, The ‘EIC Scaling Club’ Case, shares preliminary lessons from supporting 120 deep-tech scale-ups across 10 market opportunities within a community of more than 500 stakeholders.
The findings point to a clear conclusion: effective acceleration is not about offering more services. It is about delivering the right support, at the right stage, with clear priorities.
How can Europe secure access to critical raw materials — and scale the hardware companies making it possible?
Lilian Schwich, Co-Founder & Co-CEO ofcylib, shares how cylib is recovering lithium from batteries using water-based technology — helping build access to critical raw materials made in Europe, for Europe.
What does Europe’s innovation ecosystem need to accelerate deep-tech growth?
Magnus Björsne, CEO ofAstraZenecaBioVentureHub, reflects on the importance of bringing start-ups, scale-ups, corporates, and policymakers closer together — not only to exchange ideas, but to build the pathways that help innovation reach the market.
What does it take for healthcare companies to scale successfully across international markets?
Ariane De Marcillac, Associate at Gilde Healthcare, shares an investor's perspective on the challenges healthcare companies face when expanding internationally – from regulatory pathways to commercialisation strategies, particularly when moving from Europe to the US.
How can deep-tech companies move from a scientific breakthrough to market impact?
Teresa Carvalho, EIC Scaling Club Mentor for the New Biotech Platforms market group, shares her perspective on helping companies bridge the gap between scientific innovation, investor expectations and long-term growth.
The Spanish scale-up from our New Space group provides satellite connectivity services for remote and hard-to-reach areas through its constellation of nanosatellites.
The Bilbao-based industrial hydrogen technology company has completed a second closing of its Series B round. The new funding will support the company's next phase of growth as it moves from technology validation to wider industrial deployment.
The deployment marks an important step for the Spanish semiconductor metrology company, as it moves towards high-volume semiconductor manufacturing.
Events
When? 24 September 2026
Where? Gothenburg, Sweden
On 24 September, the EIC Scaling Club will head to AstraZeneca’s R&D site for a roadshow with AstraZeneca BioVentureHub and Medtronic. We’ll bring together Scaling Club health companies, corporates, and investors focused on next-generation biotech, cardiovascular therapies and tools that speed up drug development and support sustainability.
.png?upscale=true&width=320&upscale=true&name=Scaleup%20Financing%20(2).png)
.png?upscale=true&width=320&upscale=true&name=Scaleup%20Financing%20(1).png)
.png?upscale=true&width=320&upscale=true&name=Scaleup%20Financing%20(3).png)
.png?upsize=true&t=1785318946762&width=230&composeType=play_button&overlayColor=%23FF0201&overlayScale=0.3&name=Thumbnail_Magnus%20Bj%C3%B6rsne%20(1).png)
